These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 772831)

  • 1. Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
    Becker AL
    S Afr Med J; 1976 Apr; 50(16):627-9. PubMed ID: 772831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety.
    Johnson G; Singh B; Leeman M
    Med J Aust; 1976 Jun; 1(24):909-12. PubMed ID: 790112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Clin Pharmacol Ther; 1980 Jun; 27(6):733-43. PubMed ID: 6991196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
    Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
    J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
    [No Abstract]   [Full Text] [Related]  

  • 10. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 15. [A double blind trial : oxprenolol/diazepam (author's transl)].
    Scharbach H
    Encephale; 1981; 7(1):51-8. PubMed ID: 7014193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
    Schlesinger Z; Ravid M; Meshulam R
    Cardiology; 1983; 70(4):199-205. PubMed ID: 6357438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oxprenolol and propranolol on systolic time intervals.
    van Herick R; Aronow WS
    Clin Pharmacol Ther; 1978 Dec; 24(6):678-82. PubMed ID: 361333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
    Andersson O; Berglund G; Bergman H; Cramér K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Lakartidningen; 1975 Nov; 72(48):4738-40. PubMed ID: 1105030
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive effects of oxprenolol and propranolol.
    Materson BJ; Michael UF; Oster JR; Perez-Stable EC
    Clin Pharmacol Ther; 1976 Aug; 20(2):142-51. PubMed ID: 780037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.